drugset / Trial / NCT04066530
A Study to Evaluate the Efficacy and Safety of AD-203
RandomizedParallel-groupDouble-blindTreatment
Summary
This is a multicenter, active-controlled , randomized, double-blinded, paralleled group clinical study to evaluate the efficacy and safety of AD-203 to demonstrate the non-inferiority of AD-203 compared with Mucosta tab. in patients with acute or chronic gastritis
Timeline
- Start
- 2019-09-23
- Primary completion
- 2020-02-26
- Completion
- 2020-02-26
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | AD-203 | Unknown | — | — |
| Comparator | Rebamipide | Small molecule | — | — |